Plant-Derived Polyphenol and LL-37 Peptide-Modified Nanofibrous Scaffolds for Promotion of Antibacterial Activity, Anti-Inflammation, and Type-H Vascularized Bone Regeneration.
Jin. Shue S; Yang. Renli R; Hu. Chen C; Xiao. Shiqi S; Zuo. Yi Y; Man. Yi Y; Li. Yubao Y; Li. Jidong J
Key Findings
- Tannic acid gives strong antibacterial action but can be cytotoxic on its own
- Grafting LL‑37 onto the scaffold reduces toxicity, enhances stem‑cell spreading, migration, and osteogenic differentiation, and promotes M2 immune‑cell polarization
- In vivo, the LL‑37‑modified scaffold improves angiogenesis, reduces inflammation, and supports type‑H vascularized bone regeneration
Practical Outcomes
- LL‑37 shows promise for antimicrobial and tissue‑repair uses, but delivering it effectively requires advanced scaffold technology. For self‑experimenters, the findings highlight the peptide’s potential but indicate it’s not yet ready for safe, at‑home applications. Future work may lead to topical or injectable LL‑37 products, but more safety and delivery research is needed.
Summary
Scientists created a thin, fiber‑based sheet coated with a plant compound (tannic acid) and the LL‑37 peptide. The coating kills mouth bacteria, calms inflammation, and helps bone cells grow, but the plant coating alone can be toxic to cells. Adding LL‑37 makes the material safer and boosts stem‑cell activity and blood‑vessel formation, leading to better bone healing in animal tests. This is a lab‑level material, not a DIY supplement or protocol.
Abstract
The regeneration of oral tissues is a challenging clinical problem because of the complex microbial and biological stress environments. Electrospun fibrous scaffolds have attracted significant interest as effective barrier membranes for guided bone regeneration (GBR); however, no mature strategy yet exists for the surface modification of fibers to provide versatility to satisfy clinical requirements. This study demonstrated a practical biosafety strategy: the combined use of plant polyphenols and LL-37 peptides to modify the fiber surface to endow the fibrous scaffold with antimicrobial activity, immunoregulation, and vascularized bone regeneration. We confirmed that the LL-37 peptides interacted with tannic acid (TA) through noncovalent bonds through experiments and molecular docking simulation analysis. In vitro experiments showed that the TA coating imparted strong antibacterial properties to the fibrous scaffold, but it also caused cytotoxicity. The grafting of LL-37 peptide promoted the spreading, migration, and osteogenic differentiation of mesenchymal stem cells and was also conducive to the M2 polarization of RAW264.7 cells. In vivo experiments further verified that the LL-37 peptide-grafted fibrous scaffold significantly enhanced angiogenesis, anti-inflammatory effects, and type-H vascularized bone regeneration. Overall, the fibrous scaffold modified by the LL-37 peptide through TA grafting has significant potential for GBR applications.
Study Information
pubmed
2023
2023-02-01T00:00:00.000Z
10.1021/acsami.2c20776
35
66